MagedMCostantineMD

Obstetrics & Gynecology • Columbus, OH

Maternal & Fetal Medicine/High Risk

Professor, Maternal Fetal Medicine, Department of Obstetrics & Gynecology, The Ohio State University

Join to view full profile

Dr. Costantine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Costantine's full profile

Already have an account?

Office
1800 Zollinger Rd
4th Floor
Columbus, OH 43221
Phone+1 614-293-2222

Fax+1 614-293-2200

Education & Training

University of Texas Medical Branch HospitalsFellowship, Maternal-Fetal Medicine, 2010
University of Cincinnati Medical Center/College of MedicineResidency, Obstetrics and Gynecology, 2004 - 2007
American University of Beirut Faculty of MedicineClass of 2001

Certifications & Licensure

OH State Medical License 2004 - 2025
TX State Medical License 2007 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Clinical Trials

Pravastatin for Prevention of Preeclampsia Start of enrollment: 2012 Aug 01
Active, not recruiting
Phase 1
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix Start of enrollment: 2015 Nov 13
Recruiting
Phase 3
Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Start of enrollment: 2016 Nov 01
Terminated
Phase 2, Phase 3
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Start of enrollment: 2018 Mar 15
Completed
Phase 3
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy Start of enrollment: 2018 Aug 03
Recruiting
Not Applicable
Pravastatin to Prevent Preeclampsia Start of enrollment: 2019 Jul 17
Active, not recruiting
Phase 3
Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia Start of enrollment: 2021 Feb 22
Completed
Not Applicable
Roles: Contact, Principal Investigator
EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE) Start of enrollment: 2024 Jun 01
Not yet recruiting
Roles: Principal Investigator
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Start of enrollment: 2024 Dec 01
Not yet recruiting
Phase 4
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Impact of hypertensive disorders of pregnancy and gestational diabetes mellitus on offspring cardiovascular health in early adolescence.
Kartik K Venkatesh, Amanda M Perak, Jiqiang Wu, Patrick Catalano, Jami L Josefon
American Journal of Obstetrics and Gynecology. 2025-02-01
Hypertensive disorders of pregnancy and gestational diabetes mellitus and predicted risk of maternal cardiovascular disease 10-14 years after delivery: A prospective c...
Kartik K Venkatesh, William A Grobman, Jiqiang Wu, Nilay S Shah, Michael Pencina
Diabetic Medicine. 2025-01-17
Placental alkaline phosphatase (PLAP): Is it exclusively placental?
Awanit Kumar, Sourabh Sharma, Maged M Costantine, Kara Rood, Rheanna Urrabaz-Garza
Placenta. 2025-01-03

Press Mentions

Ohio State to Study Approaches to Managing Blood Pressure After PregnancyDecember 5th, 2024
Expanding Convergent Research: Ohio State’s Team Science EcosystemOctober 16th, 2024
Prescribing Without Data: Doctors Advocate for the Inclusion of Pregnant People in Clinical ResearchMarch 22nd, 2022
Join now to see all